Respiratory Diseases

>

Latest News

FDA Gives Green Light to Ensifentrine for Maintenance Treatment of COPD in Adults / image credit  ©Waldenmarus/stock.adobe.com
FDA Gives Green Light to Ensifentrine for Maintenance Treatment of COPD in Adults

June 27th 2024

The dual PDE3/PDE4 inhibitor is the first inhaled product with a novel mechanism of action approved for COPD in 2 decades and is delivered via standard jet nebulizer.

©Kateryna_Kon/stock.adobe.com
Phase 3 Trial of Combination Flu/SARS-CoV-2 Vaccine Meets All Primary Endpoints: Moderna

June 11th 2024

FDA Approves First mRNA Vaccine Against RSV for Adults Aged ≥60 Years: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves First mRNA Vaccine Against RSV for Adults Aged ≥60 Years: Daily Dose

June 7th 2024

FDA Approves Moderna's mRESVIA, First mRNA Vaccine Against RSV, for Adults Aged ≥60 Years / image credit FDA approval ©Waldenmarus/stock.adobe.com
FDA Approves Moderna's mRESVIA, First mRNA Vaccine Against RSV, for Adults Aged ≥60 Years

June 3rd 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.